Cite
HARVARD Citation
Siena, S. et al. (n.d.). O-024Entrectinib in NTRK-fusion positive gastrointestinal cancers: integrated analysis of patients enrolled in three trials (STARTRK-2, STARTRK-1, and ALKA-372-001). Annals of oncology. p. . [Online].